Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.

<h4>Background</h4>Recently, we have shown that intraplaque mast cell numbers are associated with atherosclerotic plaque vulnerability and with future cardiovascular events, which renders inhibition of mast cell activation of interest for future therapeutic interventions. However, the en...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sanne Willems, Daniël van der Velden, Paul H A Quax, Gert Jan de Borst, Jean-Paul P M de Vries, Frans L Moll, Johan Kuiper, René E M Toes, Saskia C A de Jager, Dominique P V de Kleijn, Imo E Hoefer, Gerard Pasterkamp, Ilze Bot
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0ed8c556a6bf41fda5b555b8937c1fcd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0ed8c556a6bf41fda5b555b8937c1fcd
record_format dspace
spelling oai:doaj.org-article:0ed8c556a6bf41fda5b555b8937c1fcd2021-11-18T08:31:35ZCirculating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.1932-620310.1371/journal.pone.0088984https://doaj.org/article/0ed8c556a6bf41fda5b555b8937c1fcd2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586471/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Recently, we have shown that intraplaque mast cell numbers are associated with atherosclerotic plaque vulnerability and with future cardiovascular events, which renders inhibition of mast cell activation of interest for future therapeutic interventions. However, the endogenous triggers that activate mast cells during the progression and destabilization of atherosclerotic lesions remain unidentified. Mast cells can be activated by immunoglobulins and in the present study, we aimed to establish whether specific immunoglobulins in plasma of patients scheduled for carotid endarterectomy were related to (activated) intraplaque mast cell numbers and plasma tryptase levels. In addition, the levels were related to other vulnerable plaque characteristics and baseline clinical data.<h4>Methods and results</h4>OxLDL-IgG, total IgG and total IgE levels were measured in 135 patients who underwent carotid endarterectomy. No associations were observed between the tested plasma immunoglobulin levels and total mast cell numbers in atherosclerotic plaques. Furthermore, no associations were found between IgG levels and the following plaque characteristics: lipid core size, degree of calcification, number of macrophages or smooth muscle cells, amount of collagen and number of microvessels. Interestingly, statin use was negatively associated with plasma IgE and oxLDL-IgG levels.<h4>Conclusions</h4>In patients suffering from carotid artery disease, total IgE, total IgG and oxLDL-IgG levels do not associate with plaque mast cell numbers or other vulnerable plaque histopathological characteristics. This study thus does not provide evidence that the immunoglobulins tested in our cohort play a role in intraplaque mast cell activation or grade of atherosclerosis.Sanne WillemsDaniël van der VeldenPaul H A QuaxGert Jan de BorstJean-Paul P M de VriesFrans L MollJohan KuiperRené E M ToesSaskia C A de JagerDominique P V de KleijnImo E HoeferGerard PasterkampIlze BotPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 2, p e88984 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sanne Willems
Daniël van der Velden
Paul H A Quax
Gert Jan de Borst
Jean-Paul P M de Vries
Frans L Moll
Johan Kuiper
René E M Toes
Saskia C A de Jager
Dominique P V de Kleijn
Imo E Hoefer
Gerard Pasterkamp
Ilze Bot
Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
description <h4>Background</h4>Recently, we have shown that intraplaque mast cell numbers are associated with atherosclerotic plaque vulnerability and with future cardiovascular events, which renders inhibition of mast cell activation of interest for future therapeutic interventions. However, the endogenous triggers that activate mast cells during the progression and destabilization of atherosclerotic lesions remain unidentified. Mast cells can be activated by immunoglobulins and in the present study, we aimed to establish whether specific immunoglobulins in plasma of patients scheduled for carotid endarterectomy were related to (activated) intraplaque mast cell numbers and plasma tryptase levels. In addition, the levels were related to other vulnerable plaque characteristics and baseline clinical data.<h4>Methods and results</h4>OxLDL-IgG, total IgG and total IgE levels were measured in 135 patients who underwent carotid endarterectomy. No associations were observed between the tested plasma immunoglobulin levels and total mast cell numbers in atherosclerotic plaques. Furthermore, no associations were found between IgG levels and the following plaque characteristics: lipid core size, degree of calcification, number of macrophages or smooth muscle cells, amount of collagen and number of microvessels. Interestingly, statin use was negatively associated with plasma IgE and oxLDL-IgG levels.<h4>Conclusions</h4>In patients suffering from carotid artery disease, total IgE, total IgG and oxLDL-IgG levels do not associate with plaque mast cell numbers or other vulnerable plaque histopathological characteristics. This study thus does not provide evidence that the immunoglobulins tested in our cohort play a role in intraplaque mast cell activation or grade of atherosclerosis.
format article
author Sanne Willems
Daniël van der Velden
Paul H A Quax
Gert Jan de Borst
Jean-Paul P M de Vries
Frans L Moll
Johan Kuiper
René E M Toes
Saskia C A de Jager
Dominique P V de Kleijn
Imo E Hoefer
Gerard Pasterkamp
Ilze Bot
author_facet Sanne Willems
Daniël van der Velden
Paul H A Quax
Gert Jan de Borst
Jean-Paul P M de Vries
Frans L Moll
Johan Kuiper
René E M Toes
Saskia C A de Jager
Dominique P V de Kleijn
Imo E Hoefer
Gerard Pasterkamp
Ilze Bot
author_sort Sanne Willems
title Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
title_short Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
title_full Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
title_fullStr Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
title_full_unstemmed Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
title_sort circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/0ed8c556a6bf41fda5b555b8937c1fcd
work_keys_str_mv AT sannewillems circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT danielvandervelden circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT paulhaquax circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT gertjandeborst circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT jeanpaulpmdevries circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT franslmoll circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT johankuiper circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT reneemtoes circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT saskiacadejager circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT dominiquepvdekleijn circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT imoehoefer circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT gerardpasterkamp circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
AT ilzebot circulatingimmunoglobulinsarenotassociatedwithintraplaquemastcellnumberandothervulnerableplaquecharacteristicsinpatientswithcarotidarterystenosis
_version_ 1718421664551665664